SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-048131
Filing Date
2015-08-11
Accepted
2015-08-11 16:01:16
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v416380_10q.htm 10-Q 314392
2 EXHIBIT 31.1 v416380_ex31-1.htm EX-31.1 8323
3 EXHIBIT 31.2 v416380_ex31-2.htm EX-31.2 8648
4 EXHIBIT 32.1 v416380_ex32-1.htm EX-32.1 6811
  Complete submission text file 0001144204-15-048131.txt   3068870

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cpxx-20150630.xml EX-101.INS 675523
6 XBRL TAXONOMY EXTENSION SCHEMA cpxx-20150630.xsd EX-101.SCH 32374
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cpxx-20150630_cal.xml EX-101.CAL 36116
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cpxx-20150630_def.xml EX-101.DEF 165305
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cpxx-20150630_lab.xml EX-101.LAB 250280
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cpxx-20150630_pre.xml EX-101.PRE 207151
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36179 | Film No.: 151043880
SIC: 2834 Pharmaceutical Preparations